Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 1/20 | 0.45 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.44 |
| ▸ | KLKB1 | P03952 | 3/20 | 0.44 |
| ▸ | F10 | P00742 | 9/20 | 0.43 |
| ▸ | RXRA | P19793 | 2/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.42 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 3/20 | 0.42 |
| ▸ | PROC | P04070 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6713256 | 0.87 | DHODH (0.41) | MAPK14CARM1KLKB1F10NPY5R | |
| SCHEMBL6783789 | 0.85 | KLKB1 (0.48) | MAPK14CARM1KLKB1F10RXRA | |
| SCHEMBL6677548 | 0.83 | KDM4E (0.40) | MAPK14CARM1KLKB1F10TRPV1 | |
| SCHEMBL4769625 | 0.83 | CARM1 (0.42) | MAPK14CARM1KLKB1F10RXRA | |
| SCHEMBL6689281 | 0.82 | KLKB1 (0.44) | MAPK14KLKB1F10RXRANR1H2 | |
| SCHEMBL6713134 | 0.81 | MAPK14 (0.53) | MAPK14RXRANR1H2NR1H3NPY5R | |
| SCHEMBL12361685 | 0.80 | F10 (0.49) | CARM1KLKB1F10F2PROC | |
| SCHEMBL2261049 | 0.80 | KLKB1 (0.45) | CARM1KLKB1F10F2PROC | |
| SCHEMBL2260222 | 0.79 | NPY5R (0.53) | KLKB1F10NPY5RF2PROC | |
| SCHEMBL2259914 | 0.79 | NPY5R (0.52) | KLKB1F10RXRANR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040235959-A1 | Insecticidal diamides | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235959-A1 | Insecticidal diamides | DDT, NRDC, NOXO1 | MAPK14 2425/4885CARM1 757/4885KLKB1 4524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.